Bausch+Lomb IPO Presentation Deck

Large and growing ~$50B addressable market Global addressable market revenue, 2019, $B 41% Vision Care¹ $16B Contact Lens BAUSCH+ LOMB 59% Consumer Health ~4% Ophthalmic Pharmaceuticals² 35% $26B AMD 18% Glaucoma Dry Eye / Other 2019-2025 Market CAGR4 ~4% 47% Source: Third party market research and management estimates 1. Vision care includes: sales from contact lenses, lens care solutions, and off-the-shelf eye care products; Consumer includes: sales from eye drops and eye vitamins 46% Implantables Surgical³ $8B 54% Capital Equipment / Other ~5% 2. AMD includes: sales from products for the treatment of wet age-related macular degeneration ("AMD") and dry AMD; Glaucoma includes: sales from products for the treatment of glaucoma; Dry Eye / Other includes: sales from products for the treatment of dry eye, diabetic macular edema ("DME"), conjunctivitis, ocular pain and inflammation, other corneal and external eye disorders, other retinal disorders, uveitis, and inherited retinal disorders, and other ophthalmology treatments 3. Implantables includes: sales from implantables; Capital Equipment / Other includes: sales from capital equipment, instruments and procedure fees 4. Expected. See Slide 2 for further information regarding forward-looking statements. 12

View entire presentation